395 related articles for article (PubMed ID: 8854020)
1. Stability of yellow fever vaccine.
Monath TP
Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
[TBL] [Abstract][Full Text] [Related]
2. Stability of 17D yellow fever virus vaccine using different stabilizers.
Adebayo AA; Sim-Brandenburg JW; Emmel H; Olaleye DO; Niedrig M
Biologicals; 1998 Dec; 26(4):309-16. PubMed ID: 10403034
[TBL] [Abstract][Full Text] [Related]
3. Long term storage studies with a new stabilised formulation of yellow fever virus vaccine.
Finter NB; Burfoot C; Young PA; Ferris R
Dev Biol Stand; 1976 Oct; 36():279-83. PubMed ID: 1030425
[TBL] [Abstract][Full Text] [Related]
4. Stability of live, freeze-dried virus vaccines.
Peetermans J; Colinet G; Bouillet A; D'Hondt E; Stephenne J
Dev Biol Stand; 1976 Oct; 36():291-6. PubMed ID: 1030427
[TBL] [Abstract][Full Text] [Related]
5. Thermostability of poliovirus and measles vaccines.
Melnick JL
Dev Biol Stand; 1996; 87():155-60. PubMed ID: 8854012
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
Collaborative Group for Studies with Yellow Fever Vaccine
Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
[TBL] [Abstract][Full Text] [Related]
7. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing the stability of live oral attenuated bacterial vaccines.
Cryz SJ; Pasteris O; Varallyay SJ; Fürer E
Dev Biol Stand; 1996; 87():277-81. PubMed ID: 8854028
[TBL] [Abstract][Full Text] [Related]
10. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
11. Effects of adverse storage on live virus vaccines.
Finter NB; Ferris R; Kelly A; Prydie J
Dev Biol Stand; 1978; 41():271-6. PubMed ID: 753656
[TBL] [Abstract][Full Text] [Related]
12. Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein.
Bonaldo MC; Garratt RC; Freire MS; Galler R
Cell Biochem Biophys; 2006; 44(3):313-24. PubMed ID: 16679518
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of rinderpest vaccine by modification of the lyophilization process.
House JA; Mariner JC
Dev Biol Stand; 1996; 87():235-44. PubMed ID: 8854023
[TBL] [Abstract][Full Text] [Related]
14. Heat-stable measles vaccine produced by spray drying.
Ohtake S; Martin RA; Yee L; Chen D; Kristensen DD; Lechuga-Ballesteros D; Truong-Le V
Vaccine; 2010 Feb; 28(5):1275-84. PubMed ID: 19944152
[TBL] [Abstract][Full Text] [Related]
15. [Is there an alternative to the amaril 17D vaccine?].
Saluzzo JF
Bull Soc Pathol Exot; 1999 Dec; 92(5 Pt 2):436. PubMed ID: 11000959
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface.
Bonaldo MC; Garratt RC; Marchevsky RS; Coutinho ES; Jabor AV; Almeida LF; Yamamura AM; Duarte AS; Oliveira PJ; Lizeu JO; Camacho LA; Freire MS; Galler R
J Virol; 2005 Jul; 79(13):8602-13. PubMed ID: 15956601
[TBL] [Abstract][Full Text] [Related]
17. Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine.
Ferguson M; Heath A
Biologicals; 2004 Dec; 32(4):195-205. PubMed ID: 15572101
[TBL] [Abstract][Full Text] [Related]
18. Study on the stability of 17D-204 yellow fever vaccine before and after stabilization.
Sood DK; Aggarwal RK; Sharma SB; Sokhey J; Singh H
Vaccine; 1993; 11(11):1124-8. PubMed ID: 8249431
[TBL] [Abstract][Full Text] [Related]
19. Stability of freeze-dried and reconstituted measles vaccines.
Peetermans J; Colinet G; Stephenne J; Bouillet A
Dev Biol Stand; 1978; 41():259-64. PubMed ID: 753654
[TBL] [Abstract][Full Text] [Related]
20. Stability characteristics of freeze-dried human live virus vaccines.
Cowdery S; Frey M; Orlowski S; Gray A
Dev Biol Stand; 1976 Oct; 36():297-303. PubMed ID: 1030428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]